{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"60"}],"units":"Participants"}],"description":"Toxicity evaluated and graded according to the National Cancer Institute, Version 3.0","groups":[{"description":"-Paclitaxel is administered first, 120 mg/m2 on days 1 and 2 every three weeks for four cycles. Cisplatin is administered at 20 mg/m2 over approximately 30 minutes daily for five days every three weeks for four courses. -The ifosfamide is given last with 1200 mg/m2 daily for five days every three weeks for four cycles.\n\npegfilgrastim\n\ncisplatin\n\nifosfamide\n\npaclitaxel","id":"OG000","title":"Paclitaxel, Ifosfamide, and Cisplatin"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"3 years","title":"Number of Patients With Treatment Related Toxicity","type":"SECONDARY","unitOfMeasure":"Participants"}